Quazepam

DB01589ApprovedIllicitSmall moleculeBenzodiazepines and benzodiazepine derivatives

Quazepam is a long-acting benzodiazepine used to manage insomnia. It was first approved in the US in 1985 and is used as a hypnotic for the treatment of insomnia.

Chemical structure of Quazepam
Mechanism
Curator reviewed · 2 references
Primary indication
Quazepam is indicated for the treatment of insomnia characterized by difficulty falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.Curator reviewed · 1 structured indication
Formula / weight
C17H11ClF4N2S · 386.794 g/mol (avg)
First approval
United States, 1985
Code names
SCH-16134
Brand names
  • Doral

Resolves to

Structure
InChIKeyIKMPWMZBZSAONZ-UHFFFAOYSA-NSMILESFC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Targets

What you can answer from here — as of September 16, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
804Drug interactionsStructured to mechanism, not free text
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
15Marketed productsAcross 2 countries and 14 labellers
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
16+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Quazepam, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account